MyCural Therapeutics is a life science startup, established in 2022 by cancer researchers from Karolinska Institutet, Linköping University, and Uppsala University in Sweden. We focus on developing small molecule MYC-binders that selectively inhibit MYC, a highly sought-after target in cancer therapy.

Our mission is to advance candidate drugs with the goal of creating an Anti-MYC cancer therapy for patients with aggressive, high-risk tumors. Our vision is to provide life-saving treatments for patients battling incurable cancers.


MyCural Therapeutics

Org chart

Teams

Offices

MyCural Therapeutics

Org chart

Teams

Offices

Related companies